In-person - Lawrence Blacher, M.D., Memorial Lecture: Diagnosis, Prognosis and Therapy in AL Amyloidosis 2024

Miami, FL US
February 22, 2024

In-Person Conference | 1 Cat. 1
Thursday, February 22, 2024 | 5:30 p.m. - 8 p.m.
Baptist Hospital, 5 MCVI Conference Room

Amyloidosis is a rare, debilitating and often fatal set of diseases. Early recognition is vital for therapy to have a meaningful effect on survival and patient quality of life. Please join us to hear amyloidosis expert Morie A. Gertz, M.D., discuss the critical need for earlier diagnosis in as well as the merits of conventional and high-dose therapy for disease management.

About Dr. Blacher

Dr. Lawrence Blacher was a pillar of the South Florida medical community. In practice for more than 40 years, he was instrumental in the founding and growth of Baptist Health Miami Cardiac & Vascular Institute and one of the original members of HeartWell, the Institute’s cardiology group. He was a strong advocate for the collaborative approach to medicine, contributing his expertise, guidance and wisdom.

A second-generation physician, Dr. Blacher took a personal approach to medicine and devoted his time and energy to listen and connect with his patients. He was a kind soul whose actions remind us that compassion and empathy are at the heart of medicine.

In late 2022, Dr. Blacher found himself on the other side of the doctor-patient relationship when he was diagnosed with AL amyloidosis, a rare disease presenting a constellation of symptoms that complicated his diagnosis and treatment. During his courageous final days, Dr. Blacher’s only wish was to increase awareness within the medical community about this cruel disease.

This program is a manifestation of his final wish. Today, we honor his memory and pay tribute to Dr. Blacher’s commitment to lifelong learning and to improving the outcomes for those with AL amyloidosis.

Learning Objectives

Upon completion of this conference, participants should be better able to:

  • Recognize clinical situations in which AL amyloidosis should be seriously considered in differential.
  • Weigh the merits of conventional and high-dose therapy as management for AL amyloidosis.
  • Apply evidence-based recommendations that allow for earlier diagnosis of this rare set of diseases and enable accurate staging and counseling about prognosis.

Who Should Attend

Cardiologists, hematologists, nephrologists, primary care physicians, general internists, neurologists, physician assistants, advanced practice registered nurses, hospitalists, nurses and other interested healthcare providers.


5:30 p.m.Welcome Reception
6:30 p.m.Opening Remarks
7:00 p.m.CME Lecture
8:00 p.m.Adjourn

Registration and Fees

This conference is offered free of charge.

Course Summary
Course opens: 
Course expires: 
Event starts: 
02/22/2024 - 5:30pm EST
Event ends: 
02/22/2024 - 8:00pm EST
Baptist Hospital 5 MCVI Conference Room
8900 N Kendall Dr.
Miami, FL 33176
United States


Morie A. Gertz, M.D., MACP
Chair Emeritus, Division of Hematology 
Roland Seidler Jr. Professor of the Art of Medicine
Chair Emeritus of the Department of Medicine
Mayo Clinic College of Medicine
Mayo Distinguished Clinician
Rochester, Minnesota

Disclosures And Resolution Of Conflict Of Interest

Morie A. Gertz, M.D., faculty for this educational activity, has no relevant financial relationships with ineligible companies* to disclose, and has indicated that the presentation or discussion will not include off-label or unapproved product usage.

Sandra Chaparro, M.D., co-director of this educational activity, receives grant/research support from Cordio, Endotronix and Impulse Dynamics.

Barry T. Katzen, M.D., planning committee member, is a consultant for Philips, Gore and Boston Scientific.

Tom C. Nguyen, M.D., planning committee member, is on the advisory board for Edwards Lifesciences.

Others involved in the planning, development and editing/review of the content have no relevant financial relationships to disclose with ineligible companies.*

*Ineligible companies - Companies whose primary business is producing, marketing, selling, re-selling or distributing healthcare products used by or on patients.


Baptist Health South Florida is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Baptist Health has been re-surveyed by the ACCME and awarded Commendation for 6 years as a provider of CME for physicians.

Baptist Health South Florida designates this live activity for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This activity has been approved for a total of 1 credit hours, CE Broker Course #20-1161552, by the Florida Boards of Medicine, Osteopathic Medicine and by the Florida Council of Physician Assistants.

This activity has also been approved for 1 credit for Nurse Practitioners, Nurses, Pharmacists and Techs. Baptist Health South Florida CE Broker Provider #50-182.

The American Academy of Nurse Practitioners Certification Board (AANPCB) accepts CEs accredited by the ACCME. Individuals are responsible for checking with the AANPCB for further guidelines.

AMA PRA Category 1 Credits™ claimed by physicians attending live events certified and organized in the United States for AMA PRA Category 1 Credits™ can be claimed through the agreement on mutual recognition of credits between UEMS and AMA, considered as being equal to the European Continuous Medical Education Credits (ECMEC©) granted by the UEMS. One AMA PRA Category 1 Credit™ is equivalent to one (1) hour of European EACCME Credit (ECMEC©). Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity.


Baptist Health South Florida presents this CME activity for use by healthcare professionals for educational purposes only. Opinions, perspectives and information presented by the faculty represent their ideas and views, and participants should carefully consider all available scientific data before acting on knowledge gained through this activity. Additionally, participants should consult the US Food and Drug Administration (FDA) for approved uses prior to prescribing medications or utilizing medical devices discussed in this activity.

While Baptist Health makes reasonable efforts to ensure that accurate information is presented, no warranty, expressed or implied, is offered. Participants should rely on their own clinical judgment, knowledge and experience before applying information acquired to their professional use.

Please login or register for a Baptist Health CME account to take this course.